Average Co-Inventor Count = 3.45
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galderma Research & Development (17 from 222 patents)
2. Centre International De Recherches Dermatologiques Galderma (2 from 44 patents)
19 patents:
1. 11731973 - Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors
2. 11518767 - MTOR inhibitor compounds
3. 10752617 - Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
4. 10618890 - Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
5. 10550110 - Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))
6. 10457637 - Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))
7. 10246422 - Heterocyclic compounds and use thereof in medicine and in cosmetics
8. 10246440 - Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))
9. 8362082 - Biphenyl compound selective agonists of gamma RAR receptors
10. 8106235 - Biphenyl compound selective agonists of gamma RAR receptors
11. 8049034 - Biphenyl compound selective agonists of gamma RAR receptors
12. 8022079 - Methods of modulating PPAR gamma-type receptors
13. 7973063 - Methods for activating PPAR gamma-type receptors
14. 7968560 - Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
15. 7626054 - Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof